Cells are able to recognize and degrade aberrant transcripts in order to self-protect from potentially toxic proteins. Various pathways detect aberrant RNAs in the cytoplasm and are dependent on translation. One of these pathways is the nonsense-mediated RNA decay (NMD). NMD is a surveillance mechanism that degrades transcripts containing nonsense mutations, preventing the translation of possibly harmful truncated proteins. For example, the degradation of a nonsense harming b-globin allele renders normal phenotypes. On the other hand, regulating NMD is also important in those cases when the produced aberrant protein is better than having no protein, as it has been shown for cystic fibrosis. These findings reflect the important role for NMD in human health. In addition, NMD controls the levels of physiologic transcripts, which defines this pathway as a novel gene expression regulator, with huge impact on homeostasis, cell growth and development. While the mechanistic details of NMD are being gradually understood, the physiological role of this RNA surveillance pathway still remains largely unknown. This is a brief and simplified review on various aspects of NMD, such as the nature of the NMD targets, the mechanism of target degradation and the links between NMD and cell growth, animal development and diseases.
INTRODUCTION
Historically, the study of the regulation of gene expression has tended to concentrate on the means by which genes are switched on and mRNAs are synthesized. However, the levels of a protein also depend on the rate at which its mRNA decays and/or is degraded. RNA degradation is especially important when the mRNA is aberrant, since its translation could result in a mutant harmful protein.
For example, a transcript might contain a premature termination codon (PTC) that would result in a truncated protein. The existence of a pathway that rapidly degrades mutated mRNAs was suggested 30 years ago when studies of several mutations in human genes, including the b-globin gene, determined that the presence of a PTC resulted in a diminished amount of mRNA [1, 2] .
Nonsense-mediated mRNA decay (NMD) is a conserved mRNA surveillance pathway that eliminates aberrant transcripts containing a PTC. In addition to its quality control function, NMD also regulates the expression of natural mRNAs with NMD-inducing features, a function that defines NMD as an important pathway to control gene expression post-transcriptionally [3] . This dual action, and the fact that up to 30% of all mutations causing human disease generate mRNAs with a PTC [4] , implies that NMD is a pathway with a huge impact on human health. A clear case where NMD amends the effects of PTC mutations is in thalassemias [5] , where patients with a PTCcontaining b-globin allele that does not trigger NMD show ineffective erythropoiesis, while those with an NMD-inducing PTC are normal [6] . NMD is not always beneficial: truncated proteins encoded by nonsense mRNAs could be functional, but they might not be produced in sufficient amounts due to degradation via NMD. This is the case in aniridia, cystic fibrosis and Duchenne muscular dystrophy [7] [8] [9] [10] [11] . This is a brief and simplified review covering various aspects of NMD, including the nature and degradation of NMD targets, and the physiological impacts of NMD, such as the NMD link to cell growth, animal development and disease. Due to space restrictions, this review does not cover work on NMD in plants ( [12, 13] and references therein).
NATURE OF NMD TARGETS Origin of NMD-inducing PTCs
mRNAs harbouring PTCs seem to comprise the major group of NMD substrates. PTCs can arise accidentally through various means, such as gene mutation, altered splicing and directed DNA rearrangements [14] [15] [16] [17] . Genome-wide analyses of splicing have revealed that most human genes can generate transcripts with differing exon content, which in many cases encode distinct proteins [18, 19] . By examining expressed sequence tags (ESTs), it has been proposed that one-third of these alternative splicing events have the potential to generate PTC-containing mRNAs [9, 20, 21] .
There are also PTCs that do not induce NMD. In mammals, this is often the case when a PTC is not followed by an intron, or when the intron is less than 55 nucleotides downstream from the PTC. This '-55' boundary rule applies to almost all studied mammalian transcripts, with a few exceptions [22, 23] and involves interactions between the NMD machinery and splicing-deposited exonexon junction complexes (EJCs, see below). In other organisms (e.g. budding yeast and Drosophila melanogaster), NMD can take place independently of an intron downstream of the PTC. In these cases, it is thought that the primary mechanism that distinguishes premature from normal termination codons involves detection of 3 0 -UTR length [24] [25] [26] . To complicate the matter, such a '3 0 -UTR length' mechanism is also found in mammals [26] , there is EJC-mediated NMD in flies (at least of reporter genes) [27] , there are features of long 3 0 -UTRs that confer immunity to NMD (at least in Drosophila) [28] and there is splicing-dependent, but EJC-independent, PTC recognition in Schizosaccharomyces pombe [29] .
NMD targets without a PTC
The full range of transcripts degraded by NMD remains largely elusive, even though a method known as gene identification by NMD inhibition (GINI) has been developed to identify NMD transcripts in a high-throughput manner [30, 31] . However, it is clear that many physiological non-mutated mRNAs are NMD substrates: genome-wide studies in Saccharomyces cerevisiae, D. melanogaster and human cells have shown that 3-10% of all mRNAs are regulated by the NMD factor up-frameshift protein 1 (Upf1) (reviewed in [6, 32, 33] ). In addition, knockout and knockdown experiments of key NMD factors suggest that NMD regulates the expression of physiological RNA transcripts involved in various cellular processes, such as stem cell development, splicing, genomic stability, amino acid homoeostasis, cell cycle, stress responses and chromosome/telomere maintenance [20, [34] [35] [36] [37] (reviewed in [38] ). This indicates a role for NMD as a translationdependent post-transcriptional regulator of gene expression. It should be noted that this type of analysis cannot distinguish between those transcripts directly stabilized by the inhibition of NMD and those indirectly stabilized by the change in levels of another NMD target. However, a strong argument that NMD regulates 'normal' gene expression comes from the appreciation that multiple transcripts from the same functional classes are targeted by NMD. For example, several of the alternatively spliced isoforms degraded by NMD are splicing-related factors.
How are these cellular transcripts recognized as NMD targets? What are the NMD-inducing features in the mRNA sequence? Many mRNAs have upstream open reading frames (uORFs) that can result in ribosomal pausing upstream of a stop codon. Transcripts with uORF were predicted to be NMD targets, a hypothesis recently confirmed in Caenorhabditis elegans [39] and Drosophila [40] . Additional potential mechanisms include long 3 0 -UTRs (see NMD mechanism), genes with retroviral or transposon insertions and genes with introns in their 3 0 -UTR [37] .
MOLECULAR MECHANISM OF NMD
Even though the NMD machinery is conserved among species, various mechanisms by which NMD can be elicited have been proposed based on studies of mammalian, Drosophila, C. elegans or S. cerevisiae cells. Many experiments on the molecular function of NMD factors will not be detailed here, as they are discussed extensively in several excellent reviews [33, [41] [42] [43] [44] [45] . There are two important questions regarding the molecular mechanism of NMD that I will discuss here: (i) how are NMD-inducing PTCs recognized and (ii) how does this recognition lead to RNA decay?
PTC recognition
It is not completely understood how the NMD machinery identifies PTCs, but a common event in virtually all NMD RNAs is that cis-acting elements downstream of a PTC informs the ribosome termination complex that translation termination is occurring early. A second conserved event in every eukaryote is that NMD depends on the group 1 RNA helicase and RNA-dependent ATPase Upf1 [Suppressor with Morphological defects in the Genitalia 2 (Smg2) /Rent1]. When the ribosome reaches a PTC, the eukaryotic translation release factors eRF1 and eRF3 interact with Upf1, resulting in the recruitment of Upf1 at the PTC [46] (Figure 1 ). In those cases where the length of the 3 0 -UTR defines the nature of the NMD target, the recognition of a stop codon as a PTC depends on the physical distance between the PTC and the cytoplasmic poly(A)-binding protein 1 (PABP). Upf1 and PABP both compete for the interaction with eRF3-if PABP is in close proximity to the PTC ( Figure 1A) , it seems to function as an NMD repressor; on the other hand, a hostile environment for the PABP-eRF3 interaction stimulates Upf1 interacting with eRF3 and induction of RNA degradation by NMD [26, [47] [48] [49] [50] (Figure 1B ). The interaction of Upf1 with the RNA can also be assisted by the mRNA 5 0 -end [51] and the 3 0 -UTR [52] (Figure 1B) . The UPF1-eRF binding stimulates Upf1 phosphorylation and promotes RNA degradation. Note however that PABP has been reported not to be required for NMD in yeast [29, 53] .
In almost all cases across eukaryotes, the action of Upf1 in 'marking' the RNA as a target for NMD is assisted by two other proteins, Upf2 (Smg3) and Upf3 (Smg4). A conformational change in Upf1 upon binding of Upf2 activates Upf1. Upf2 binds Upf3 [54] [55] [56] , and in vitro analyses showed that either Upf2 alone or the Upf2-Upf3 complex, but not Upf3 alone, bind to RNA [57] (Figure 1B) . However, in vivo data in flies and fish suggest that the binding of Upf2 to Upf1 is more important for most, if not all, NMD targets than the binding of Upf2 to Upf3 [40, 58] . Upf2 and Upf3 are loaded onto the RNA downstream of the PTC, either by interactions with the EJC or by other unknown mechanisms.
The presence of the Upf1-eRFs complex at the PTC, as well as the Upf2/Upf3 complex being far enough downstream of the PTC, induces the phosphorylation of Upf1 by the kinase Smg1 (Smg1 activity is also regulated by Smg8 and Smg9 [59] [60] [61] ). This Smg1/Upf1/RF complex is termed SURF [46] . Upf1 phosphorylation induces the recruitment of three proteins, Smg5-7, that are essential for exoand endo-nucleolytic mRNA degradation ( [62, 63] and references therein; Figure 1C and see below).
A major NMD feature in human cultured cells, but not key in other systems, are the splice junctions and the multi-protein EJCs positioned downstream of the PTC. The EJC is composed of four core proteins (the dimer Mago/Y14, Barentsz and eIF4a3, reviewed in [64] ) and additional, more peripheral, proteins that probably confer the specificity of the EJC in various post-transcriptional processes, including NMD and RNA localization [65] . In the case of NMD, the four core proteins are deposited onto the RNA upon splicing (around 24 nucleotides upstream of the exon-exon junctions), and 'talk' to the terminating ribosome through a 'bridge' created by the Upf1/Upf2/Upf3 complex ( Figure 1C ). This SURF/Upf2/3/EJC complex is called decayinducing complex (DECID) [59] and induces the phosphorylation of Upf1 and the degradation of the transcript ( Figure 1C ).
Target degradation
As mentioned above, Upf1 phosphorylation induces recruitment of Smg5, Smg6 and Smg7, essential proteins for exo-and endo-nucleolytic degradation of the NMD mRNA. Depletion of any of these proteins inhibits NMD in various organisms and cultured cells [66] , and it is known that Smg5, Smg6 and/or Smg7 are involved in the dephosphorylation of Upf1 [67] . However, little is known about the precise mechanism that triggers the rapid degradation of nonsense mRNAs, and how the Upf1 phosphorylation/dephosphorylation cycle, mediated by the Smg proteins, activates decay.
In brief, NMD targets can be degraded via three mechanisms: an Smg6-dependent endonucleolytic pathway, a deadenylation pathway and a decapping pathway (both deadenylation-dependent and -independent). The resulting fragments are degraded in the 3 0 !5 0 direction by the exosome and in the 5 0 !3 0 direction by Xrn1. The deadenylation and decapping pathways depend on Smg5/Smg7, factors that provide a link between the target and the 0 -UTR, and stalls, and the decay factor Upf1 is recruited by the termination factors (eRF). The stable binding of Upf1 to eRFs induces a cascade of event that leads to RNA degradation ( Figure 1C ). The interaction of Upf1 with the RNA is also assisted by signals from the 3 0 -UTR (RNA features or RNA-binding proteins), and by the mRNA 5 0 -end (red arrows). (C) The presence of the Upf1^eRFs complex at the PTC, as well as the Upf2/Upf3/EJC complex being far enough downstream of the PTC, induces the phosphorylation of Upf1 by the kinase Smg1. Upf1 phosphorylation induces the recruitment of three proteins, Smg5^7, that are essential for exo-and endo-nucleolytic mRNA degradation. The resulting fragments are degraded in the 3 0 !5 0 direction by the exosome and in the 5 0 !3 0 direction by Xrn1. Symbols: eRF, translation release factor; PABP, poly(A)-binding protein; STOP, stop codon; PTC, premature termination codon; Upf1^3, up-frameshift suppressor 1^3; EJC, exon junction complex; Smg1^7, suppressor with morphological effect on genitalia 1^7; P, phosphate.
general cellular mRNA decay enzymes (reviewed in [68] ).
Research on S. cerevisiae NMD, which lacks Smg6 [68] , suggests that nonsense mRNAs are rapidly degraded through both deadenylation-independent and deadenylation-dependent decapping [69, 70] . Decapping depends on the recruitment of the decapping enzyme Dcp2/Dcp1 to the RNA. An interaction between Upf1 and Dcp2 has been identified, which might recruit Dcp2 to the target [71] .
In Drosophila NMD, which lacks Smg7, degradation is mainly mediated by the endonuclease pathway. Smg6 contains a PIN-endonuclease domain that is required for cleavage of target mRNAs [72] [73] [74] [75] . Smg6 seems to be recruited to target mRNAs by the interaction of its 14-3-3-like domain with phosphorylated Upf1 [62] and cleaves in close proximity to the PTC. In mammalian cells, Smg6 is also recruited to target mRNAs through direct interaction with the EJC [76] . However, recent work has shown that in the absence of Smg6, Drosophila NMD is reduced, but not eliminated. Therefore, flies without Smg6 are still able to degrade NMD targets [66] . Since Smg6 is not absolutely required for NMD in Drosophila, and flies do not have Smg7, how are the targets degraded in this organism? Inactivation of the decapping pathway in Drosophila cultured cells does not affect NMD degradation [75] , but it is still possible that this mechanism is used only in the absence of Smg6. The study of smg6-mutant alleles that specifically disrupt the PIN domain suggests that Smg6 has also some PIN-independent function [66] .
In mammalian cells, all three degradation pathways have been described (reviewed in [68] ). What then determines which route is taken by the different types of mRNAs directed to NMD decay? Is binding of Smg6 or the complex of Smg5/7 an important deciding point?
NMD AND CELLULAR GROWTH
There is a strong link between some NMD factors and cell growth. For example, Drosophila cultured Schneider (S2) cells depleted of upf1 and upf2 arrest at G2/M phase [77] . This observation correlates with in vivo studies that show that Drosophila Upf1 and Upf2 provide a competitive growth and/or survival advantage to proliferating cells. Clones of upf1-or upf2-mutant cells in an otherwise non-mutant epithelium are much smaller than the control clones [40] . This lack of growth capacity of the upf1-and upf2-mutant cells is partially rescued by expressing an inhibitor of apoptosis, suggesting that the clones are small due to a combination of reduced proliferation and induction of cell death via apoptosis. Occasionally, an epithelium formed of only mutant cells is observed, showing that when there are no competing wild-type cells, mutant cells can divide to form a normal epithelium. Similarly, in the Drosophila eye, smg6-, upf1-and upf2-mutant cells are defective in cell proliferation when in competition with wild-type cells [66, 78] . When competing cells are removed, the eye can be formed by mutant cells. Depletion of upf3 and smg5 in S2 cells results only in a weak increase in the proportion of G2/M cells [77] . Accordingly, upf3-mutant clones do not show obvious growth defects and their size matches control clones [40] .
In mice, Upf1-mutant blastocysts show potent induction of apoptosis and are unable to generate stable embryonic stem cell lines [79] . Similarly, Smg1-mutant embryos undergo massive apoptosis [80] . Furthermore, haematopoietic-specific production of a truncated Upf2 led to the extinction of all haematopoietic progenitor (but not differentiated) cells, suggesting that NMD is mainly essential for proliferating cells [34] . Similarly to mice and flies, human Upf1 is required for S phase progression in cultured cells [81] . However, the reduction of Upf2 levels in human tissue culture has no effect on cellular proliferation. Although this result suggests that the function of Upf2 in cell division is not conserved in humans, it is important to note that the depletion of Upf2 was only partial, and that residual Upf2 might support its function in cell growth. Alternatively, it is possible that Upf1 regulates cell growth independently of its NMD function. For example, in human cells, Upf1 has additional roles that are likely unrelated to NMD. These roles involve telomere maintenance, cell cycle progression and DNA replication [82] .
How might NMD regulate growth? Tumor suppressor genes exhibit a disproportionate number of nonsense mutations [83] . For example, PTCs are found in several tumor suppressor genes, such as BRAC1, BRAC2, Wilms' tumor 1, p53 and RB. Furthermore, the strategy GINI (see above) has identified tumor suppressor genes, and NMD seems to play a role in carcinogenesis ( [84] and references therein). Tumor suppressor proteins inhibit proliferation and/or promote apoptosis. Therefore, it is possible that the up-regulation of tumor suppressor NMD targets is responsible for the inhibition of cell division and induction of apoptosis observed in upf1-or upf2-mutant cells: in this way, inhibition of NMD would result in the higher expression of a tumor suppressor gene, and consequently, a reduction in cell division and an enhancement in apoptosis. On the other hand, the increased mRNA stability might result in high levels of a truncated 'mutant' tumor suppressor that might increase cellular growth. For example, one mutant p53 transcript found in breast cancer shows increased mRNA stability with the inhibition of NMD, and in addition, the truncated p53 is more stable than the wild-type protein [85] . In any case, it has not yet been shown that any of the produced truncated tumor suppressors can affect the phenotype of the cell.
The link between NMD and growth is unlikely only to be through growth genes. Other described NMD targets are transcripts of the unfolded protein response (UPR), an endoplasmic reticulum (ER) stress response pathway that is activated when unfolded proteins accumulate in the ER. Many of these UPR transcripts (e.g. ATF-4 and CHOP) are detrimental to cellular proliferation and survival when highly expressed in non-stressed cells. Further links between NMD and the ER have recently been shown, since defects in Smg1, Upf3 and Smg6 in C. elegans and Smg6 in mammalian cells cause ER stress [86] . All these interesting correlations between cellular growth and growth genes as NMD targets warrant further attention in the future.
FUNCTION OF NMD IN ORGANISM DEVELOPMENT
The importance of NMD effectors in cell viability and organism development varies across species, as described in detail in two recent reviews [12, 87] . In summary, NMD factors and NMD per se are not essential for C. elegans development but NMD factors, if not NMD per se, are required for embryogenesis in D. melanogaster and in vertebrates. It is currently difficult to attribute specific developmental defects to NMD inhibition because of the roles of a number of NMD factors in one or more cellular processes, in addition to NMD. Furthermore, in cases where NMD is essential for proper embryonic development, it is difficult to know which is more important-the NMD-mediated elimination of PTC transcripts or the NMD-mediated regulation of physiologic transcripts. For this reason, I have organized this section by organism:
Yeast: The loss of Upf1-3 in S. cerevisiae [88] [89] [90] [91] and Upf2 in S. pombe [29, 92] results in no apparent growth abnormality. On the other hand, deletion of S. pombe Upf1 produces abnormally long cells, probably due to problems with cell-cycle progression (De, S and Brogna, S personal communication).
Caenorhabditis elegans: Inactivation of any of the NMD factors in C. elegans leads to viable worms that present mild morphological effects on the genitalia [93] (thereof the name given to Smg genes), showing that NMD is apparently dispensable for worm viability, although necessary for the correct morphogenesis of the reproductory structures. Nevertheless, the highly conserved Smgl1 and Smgl2, recently identified as critical NMD factors [25] , are essential for viability, which suggests that they may be involved in additional cellular functions.
Drosophila melanogaster: All Upf and Smg proteins play a role in NMD in S2 cells [77] . Drosophila Upf1 and Upf2 are essential for viability, since upf1 and upf2 are lethal as null alleles. Furthermore, loss of the Upf1-Upf2 interaction is not compatible with viability [40] . upf1 and upf2 mutants survive through larval stages due to maternal contribution, since the germline provision of Upf1 and Upf2 is essential for embryonic development and patterning of the follicular epithelium. In contrast, deletion of Upf3, Smg1 or Smg6 renders viable flies [40, 66, 78, 94] . In general, none of the cellular growth and developmental defects observed in upf1 and upf2 mutants are seen in upf3-or smg1-mutant flies, although upf3 mutants develop slightly slower than wild-type. Loss of Smg6 leads to a moderate reduction in viability.
What is the link between viability in fly mutants and NMD? Are upf1 and upf2 essential genes because of their function in NMD? And if so, why are not Upf3, Smg1 and Smg6 essential genes? In general, the severity of NMD mutations and organismal viability are correlated in Drosophila: the strongest inhibition of NMD in null upf1 and upf2 alleles results in death, while deletion of Upf3, Smg1 or Smg6 has moderate effects on NMD and renders viable flies. This correlation seems also to be maintained regarding the requirements for NMD factors in cellular growth (see above). It is especially surprising that smg6 (see 'Target degradation' section) and smg1-mutant flies show a moderate effect on the stabilization of NMD targets, when compared with upf1 and upf2 mutants. In the case of Smg1, this begs the question of how Upf1 is phosphorylated in the mutant flies and suggests that there are other kinases for those targets less sensitive to Smg1 depletion.
Danio rerio: As in Drosophila, knockdown of upf1, upf2 in zebrafish causes embryonic lethality, whereas depletion of Smg1 has no effect on viability or embryogenesis [58] . Smg5-7 are also essential for embryogenesis in the fish, which at least for Smg6 is contrary to what is observed in the fly. Embryos injected with Upf1 morpholinos exhibit extensive necrosis in the central nervous system, impaired eye development, abnormal somite morphogenesis and perturbation in the posterior axis elongation and in the yolk sac extension. The phenotypes caused by Upf2, Smg5, Smg6, DHX34 (Smgl1) [95] and NBAS (Smgl2) [95] depletions resemble that of Upf1-depleted embryos. Smg7 morphants also display some of these phenotypes, but the nervous system defects show specific features that are not observed in other cases. The phenotypic similarities between Upf1, Upf2, Smg5 and Smg6 morphants suggest that the observed defects are likely due to the inhibition of NMD, while Smg7 may have acquired additional functions.
The existence of two paralogues of Upf3 (a and b, or Upf3 and Upf3x) in vertebrates has made the study of Upf3 knockout animals difficult. In zebrafish, the double Upf3a/b knockdown shows phenotypes comparable to the weak phenotypes observed in upf1 brains, but embryonic survival was not strongly compromised. The down-regulation of Upf3a alone had only minor effects on brain development, and knockdown of Upf3b had no detectable consequence.
Mammals: As yet, no phenotypic data for Upf3 knockout mice exist, but similar to zebrafish, mouse Upf1, Upf2 and Smg1 knockouts cause early embryonic lethality [34, 79, 80] . In the case of Upf1, mutant blastocysts show induction of apoptosis and are unable to generate stem cell lines. As in flies, it is possible that cellular lethality may initiate in mutant embryos once the oocyte-derived Upf1 is exhausted, an idea that is further supported by the presence of Upf1 RNA in oocytes [79] . The loss of Upf2 in the haematopoietic system shows a requirement for Upf2 in the maintenance of all tested stem and progenitor subsets within the bone marrow and, consistent with this, depletion of Upf2 was accompanied by severe anaemia [34] . Furthermore, elimination of Upf2 during T-cell development results in thymic atrophy, with reduced numbers of T-lymphocytes, and accumulation of PTCþ T-cell receptor b mRNAs. Upf2 is also essential for liver development, function and regeneration [96] . Finally, Smg1-mutant embryos lack a vascular system and undergo massive apoptosis [80] .
Increasing evidence, including the NMD-mutant phenotypes observed in the fish, suggests that the NMD pathway is involved in the development and function of the nervous system. In mice, NMD is repressed during neuronal development to allow for the stabilization of NMD targets that encode for neuronal factors [97, 98] . Furthermore, the balance of expression between two proteins, PTB and nPTB, controls a widespread alternative splicing program during neuronal development. This balance involves the NMD-mediated degradation of nPTB mRNA [99] . The function of NMD in neurons seems to be conserved in flies, since mutation of smg1, upf2 or smg6 reduces neurotransmission and synaptic-vesicle cycling [100] .
Apart from the studies both in vitro and with cultured cells, as described in various sections of this review, there is not much information on the impact of mutations in human NMD factors. The only data available in humans indicate that Upf3b (also known as Upf3X)-deficient males (since it is X-linked) develop intellectual disability, suggesting that even if Upf3a and Upf3b have overlapping functions, the loss of one of these paralogues is enough to perturb human development [101, 102] . This work also shows that at least some affected males survive embryogenesis.
NMD AND DISEASES
In man, mutations in Upf3b cause intellectual disability, along with other neurological defects, which includes autism, hyperactivity disorder and schizophrenia. In addition, up to 30% of all mutations causing human disease generate mRNAs with a PTC [4] , which further indicates that NMD seems to be a pathway with a huge impact on human health. As mentioned above, it has been shown that a b-globin-mutant allele that contains an NMD-inducing PTC does not show ineffective erythropoiesis, contrary to a PTC allele that is not an NMD target. Thus, NMD amends the effects of PTC mutations in b-thalassemias. NMD is not always beneficial, and in those cases in which NMD is detrimental, it is important to reduce NMD activity in order to maximize the impact of suppression therapies. Suppression therapy is a treatment strategy for diseases caused by nonsense mutations. This approach uses pharmacological agents that suppress translation termination at PTCs (e.g. PTC124) so that the translation of a full-length (mis-sense-mutated, but functionally active) protein is restored [103] . This type of treatment ameliorates NMD-provoking diseases, as shown for cystic fibrosis and muscular dystrophy [11, 103] . Thus, the inhibition of NMD may be an achievable target for the pharmacologic treatment of many diseases. There are currently two types of inhibitors of NMD: Smg1 kinase inhibitors, such as wortmannin and caffeine, and the natural product pateamine, which interacts with eIF4AIII.
Although it is obvious that NMD somehow affects cell and tissue growth (see above), and that NMD regulates transcripts that are relevant in cancer, it is unclear whether this regulation would result in proteins (or in expression levels) with tumorigenic properties. Experimental validation that NMD modulates the effects of deleterious mutations in cancer is still necessary.
Retroviral full-length RNA is presented to the host translation machinery with characteristics rarely observed among host cell mRNAs: a long 3 0 -UTR, retained introns and multiple open reading frames. As a result, the viral RNA is predicted to be recognized by the host NMD machinery, and degraded. However, viruses seem to have developed systems to evade NMD. For example, in the case of the Rous sarcoma virus, there is a stability element, which resides immediately downstream of the gag termination codon and facilitates NMD evasion [104] .
In summary, the medical significance of the NMD pathway is highlighted by studies which revealed that there are various clinical conditions in which NMD modulates disease phenotypes [6] .
CONCLUDING/OTHER REMARKS
NMD is obviously an important pathway for RNA quality control, as well as for the post-transcriptional regulation of gene expression. Although there has been a great advance in understanding the mechanism of the pathway, as well as its impact on cellular physiology, there are still many unknowns. An important future area of interest is the identification of NMD targets that are responsible for any of the mutant developmental phenotypes described so far, especially when considering that the secondary effects of depleting NMD could go further than the mere stabilization of the direct targets. To this, one needs to add the likely complexity of tissue-and stage-specific NMD requirements.
An aspect of the pathway where some progress has been made, but that is not covered in this review, is the link between NMD and other cellular processes. For example, there is a tight relationship between alternative splicing and NMD ( [105] and references therein). This coupling, initially discovered for SR proteins in C. elegans [106] , is known as regulated unproductive splicing and translation (RUST), or alternative splicing coupled to NMD (AS/NMD) showed that NMD affects the outcome of alternative splicing by degrading mRNA isoforms with PTCs. In addition, The AS/ NMD link also comprises a feedback loop by which the NMD-regulated alternative spliced proteins modulate the splicing of their own (and probably other) mRNAs.
Some studies have suggested that PTCs can affect the splicing process directly ( [107] and references therein), although a pathway described as 'nonsensemediated up-regulation of pre-mRNA' was later attributed to other factors not involving recognition of a PTC. A recent study has shown that certain unspliced precursors are degraded efficiently only when both the nuclear exosome and NMD pathways are active, suggesting that a functional redundancy exists between nuclear and cytoplasmic degradation pathways for unspliced pre-mRNAs [108] . NMD seems to also be linked to other RNA processing events, such as the microRNA pathways [97] .
Another area of significant importance is the study of how NMD is regulated. In human cells, the NMD pathway is auto-regulated [109, 110] , and this might also be the case in flies, since as in human cells, the Smg5 transcript is an NMD target in cultured cells and in embryos [40, 77, 111] . In addition, NMD can be regulated by a wide variety of cellular stresses, such as amino acid deprivation and hypoxia (which activates the UPR), which would allow a gene expression response to these stimuli [32, 112] .
largely elusive, many physiological non-mutated mRNAs are also degraded by NMD. The molecular mechanism of NMD: How are NMD targets recognized and degraded by the NMD factors? Even though the NMD machinery is conserved among species, there are various mechanisms by which NMD can be elicited. Common to all of them is the action of the stalled ribosome and the helicase Upf1. The impact of NMD on cellular growth: NMD provides a competitive growth and/or survival advantage to proliferating cells. This link between NMD and cell growth might be through the regulation of expression of both tumor suppressor and stress response genes. The impact of NMD on the development of an animal: description of the developmental phenotypes, organism by organism, when NMD factors are mutated. The link between NMD and human health: Is the inhibition of NMD an achievable target for the pharmacologic treatment of diseases?
